0920-24AA Lead Evaluator Survey

Lead Evaluator Survey
Form Approve
OMB No: xxxx-xxxx
Exp. Date: xx-xx-xxxx
The public reporting burden of this information collection is estimated at 30 minutes, including the time for reviewing
instructions, searching existing data sources, gathering, and maintaining the data needed, and completing and reviewing the
collection of information. An agency may not conduct or sponsor; a person is only required to respond to a collection of
information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any
other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports
Clearance Officer, 1600 Clifton Road NW, MS D-74, Atlanta, GA 30333; Attn: PRA (xxxx-xxxx).

INTRODUCTION
1. In which state/territory is your RPE organization doing work?
2. Does your RPE organization employ internal evaluation staff, external evaluation staff (e.g.,
contractors), or both internal and external evaluation staff?
a. Internal evaluation staff
b. External evaluation staff
c. Internal and external evaluation staff
3. If your organization employs external evaluation staff, please indicate the type of employer:
a. Contracting agency (please provide name)
b. University (please provide name)
c. Other (please provide name)
PROGRESS TOWARD GOALS
4. What evaluation measure(s) is being used to monitor progress towards NOFO strategies and
activities?
Strategies and activities
Build internal capacity to facilitate and monitor implementation
Build capacity for partner organizations
Conduct or leverage a primary prevention capacity assessment with a health
equity focus
Participate in CDC sponsored activities
Develop or enhance existing State/Territory/Tribal Action Plan with partners
Leverage multi-sector partners towards SV prevention
Engage multi-sector partners including but not limited to SA and Tribal
Coalitions

Associated evaluation measure

Identifying, implementing, and adapting SV prevention strategies at the
community and societal level focused on reducing disparities
Gather and synthesize publicly available data
Use data to identify and select prevention strategies
Develop and implement an equity focused evaluation plan
Increase access to and use of monitoring and evaluation data to improve SV
prevention implementation
5. To what extent has your RPE organization made progress in the following short-term outcomes?
Please base your responses on your most recent evaluation findings.
Level of Progress
Not yet
measured
Increased
capacity/understanding of
capacity to implement and
evaluate primary prevention
of SV at the community- and
societal- levels within
SHDs/in Indian Country
Increased capacity to
promote and incorporate
health equity program
activities relevant to SV
prevention among partner
organizations
Increased partner and
community awareness of
states/territories/tribal
efforts to prevent SV and the
disproportionate burden of
SV
Increased partner and
community awareness of
effective primary prevention
strategies and the disparate
burden of SV
Increased coordination and
collaboration among partners
and between SHDs, SA
coalitions, Tribal SA
coalitions, representatives
from underserved

No progress

Very little
progress

Moderate
progress

Substantial
progress

How this is
measured

communities and other
sectors to prevent SV
Increased community and
society-level implementation
of SV prevention strategies
Increased implementation of
prevention strategies among
communities and populations
with disproportionately high
rates of SV
Increased implementation of
prevention strategies that
seek to prevent SV by
addressing social and
structural determinants of
health
Increased awareness of
availability of data to
understand inequities within
tribal populations and
communities with
disproportionately high rates
of SV
Increased access and use of
data to understand inequities
within populations and
communities with
disproportionately high rates
of SV
Increased monitoring and
evaluation activities and
sharing of data related to SV
prevention
6. Please provide a brief explanation of any challenges faced related to measurement of shortterm outcomes (750 characters).
7. To what extent has your RPE organization made progress in the following intermediate-term
outcomes? Please base your responses on your most recent evaluation findings.
Level of Progress
Not yet
measured
Increased capacity for
statewide program

No
progress

Very little
progress

Moderate
progress

Substantial
progress

How this is
measured

implementation and SV
prevention
Increased partner support to
implement, evaluate, and
adapt state- and communitylevel strategies to prevent SV
Increased reach of
prevention strategies that
impact communities and
populations with
disproportionately high rates
of SV
Increase in number of
community- and societallevel strategies that promote
health equity and reduce
inequities in SV by addressing
social and structural
determinants of health
Increase in protective factors
and decrease in risk factors
associated with SV
Increased access to data to
understand inequities within
tribal populations and
communities with
disproportionately high rates
of SV
Increased use of data-driven
decision making to reduce
inequities impacting
populations and
communities with
disproportionately high rates
of SV
Increased state- and
community-level monitoring
of trends in SV outcomes and
SDOH
8. Please provide a brief explanation of any challenges faced related to measurement of
intermediate-term outcomes. (750 characters)
DATA USE AND ACCESS
9. What barriers has your RPE organization experienced with respect to accessing data? How are
you addressing those barriers? (750 characters)

10. What facilitators has your RPE organization experienced with respect to accessing data? (750
characters)
EVALUATION CAPACITY AND PROGRESS
11. As of today, how would you describe the status of your RPE organization’s evaluation activities?
a. Experiencing significant delays
b. Experiencing minor delays
c. On track

12. What challenges have affected your RPE organization’s evaluation progress to date? How are
you addressing those challenges? (1000 characters)
13. What has facilitated your RPE organization’s evaluation progress to date? (1000 characters)
14. Please describe how key partners have supported your RPE organization's evaluation capacity.
(750 characters)
15. Please describe any changes made to your evaluation plan and the reason for those changes
(e.g., changes in evaluation design, data collection, analysis methods, outcomes and indicators,
product dissemination). (1,000 characters)
16. To what extent has your RPE organization used its evaluation data?
a. Not at all
b. A little
c. Somewhat
d. A great deal
17. What barriers has your RPE organization experienced with respect to using evaluation data for
continuous program improvement? How are you addressing those barriers? (750 characters)
18. What facilitators has your RPE organization experienced with respect to using evaluation data
for continuous program improvement? (750 characters)
19. How have evaluation findings been used to inform your RPE organization’s program activities?
(750 characters)
20. How is your RPE organization aligning its program- and policy-level evaluation with
state/territory-level evaluation? (750 characters)
21. How would you rate the capacity of your RPE organization’s sub-recipients to evaluate sexual
violence prevention activities?

a.
b.
c.
d.
e.

Extremely low
Moderately low
Adequate
Moderately high
Extremely high

22. What factors have impacted your RPE organization's sub-recipients' capacity to evaluate SV
prevention activities? (750 characters)
23. What evaluation-related trainings has your RPE organization provided to its partners? Which
types of partners (e.g., health services, government, education, law enforcement, etc.)
participated in these trainings?
Training Provided

Types of Partner(s) Participated

24. What evaluation products has your RPE organization developed? How does your RPE
organization plan to disseminate its evaluation products, and to which audiences? (1200
characters)
TECHNICAL ASSISTANCE
25. Which types of technical assistance and support from the CDC and technical assistance partners
have been useful to your RPE organization? (1000 characters)
26. How could technical assistance and support from CDC and technical assistance partners be
improved? (1000 characters)
CONCLUSION
27. Thank you so much for taking the time to complete this survey! If you have any additional
comments on evaluation, please provide them here. (1000 characters)